Etiologic considerations in the patient with syncope and an apparently normal heart

Archives of Internal Medicine

Volumn 163, Issue 2, 2003, Pages 151-162

  Goldschlager, Nora ^a   Epstein, Andrew E ^b   Grubb, Blair P ^c   Olshansky, Brian ^d   Prystowsky, Eric ^e   Roberts, William C ^f   Scheinman, Melvin M ^g  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e Care Group   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; CARDIOGENIC SHOCK; CAROTID SINUS SYNDROME; CONSCIOUSNESS DISORDER; CORONARY ARTERY ANOMALY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE; FAMILY HISTORY; HEART ARREST; HEART DISEASE; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMOPERFUSION; LONG QT SYNDROME; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECALL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; THORAX RADIOGRAPHY; TORSADE DES POINTES;

ALGORITHMS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS; HYPOTENSION, ORTHOSTATIC; LONG QT SYNDROME; PHYSICAL EXAMINATION; SPORTS; SYNCOPE; SYNCOPE, VASOVAGAL; TACHYCARDIA, VENTRICULAR; TILT-TABLE TEST;

EID: 0037467775     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.2.151     Document Type: Review

References (39)

1. Grubb BP. Neurocardiogenic syncope. In: Grubb BP, Olshansky B, eds: Syncope: Mechanisms and Management. Armonk, NY: Futura; 1998.
2. Lurie KG, Iskos D, Sakaguchi S, Fahy GJ, Benditt DG. Resumption of motor vehicle operation in vasovagal fainters. Am J Cardiol. 1999;83:604-606.
3. Li H, Weitzel M, Easley A, Barrington W, Windle J. Potential risk of vasovagal syncope for motor vehicle driving. Am J Cardiol. 2000;85:184-186.
4. Grubb BP. Pathophysiology and differential diagnosis of neurocardiogenic syncope. Am J Cardiol. 1999;84(suppl):3Q-9Q.
5. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol. 1996;28:263-275.
6. Grubb BP. Neurocardiogenic syncope and related syndromes of orthostatic intolerance. Cardiol Rev. 1997;5:182-190.
7. Kenny RAM, Richardson DA, Steen N, Bexton DM, Shaw FE, Bond J. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 2001;38:1491-1496.
8. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol. 1997;79:145-149.
9. Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH. Syncope associated with supraventricular tachycardia; an expression of tachycardia rate or vasomotor response? Circulation. 1992;85:1064-1071.
10. Marcus FI, Fontaine GH, Giraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384-398.
11. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
12. Guiraudon GM, Klein GJ, Gulamhussein SS et al. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation. 1983;67:463-470.
13. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36:1-12.
14. Zhang L, Timothy KW, Vincent GM, et al. Spectrum of the ST-T wave patterns and repolarization parameters in the congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102:2849-2855.
15. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343:262-267.
16. Roden DM. Acquired long-QT syndromes and the risk of proarrhythmia. J Cardiovasc Electrophysiol. 2000;11:938-940.
17. Little RE, Kay GN, Cavender JB, Epstein AE, Plum VJ. Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol. 1990;13:164-170.
18. Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia, Ann Intern Med. 2000;133:881-885.
19. Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for health-care professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1999;99:979-982.
20. Bryer-Ash M, Zehnder J, Angelchik P, Maisel A. Torsades de pointes precipitated by a Chinese herbal remedy. Am J Cardiol. 1987;60:1186-1187.
21. Tai YT, But PP, Young K, Lau CP. Cardiotoxicity after accidental herb-induced aconite poisoning, Lancet. 1992;340:1254-1256.
22. Hailer CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
23. Stolt A, Karila T, Viitasalo M, Mantysaari M, Kujala UM, Karjalainen J. QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol. 1999;84:364-366.
24. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol. 1999;33:5-15,
25. 3. Circulation. 2002;105:73-78.
26. Moss AJ. Phenotype (ECG)-genotype consideration in long QT syndrome and Brugada syndrome. J Cardiovasc Electrophysiol. 2000;11:1055-1057.
27. Kertesz NJ, Fenrih AL, Friedman RA. Congenital complete atrioventricular block. Tex Heart Inst J. 1997;24:301-307.
28. Michaelsson M, Riesenfeld T, Jonzon A. Natural history of congenital complete atrioventricular block. Pacing Clin Electrophysiol. 1997;20:2098-2101.
29. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493-1501.
30. Chu E, Cheitlin MD. Diagnostic considerations in patients with suspected coronary artery anomalies. Am Heart J. 1993;126:1427-1428.
31. Taylor AJ, Byers JP, Cheitlin MD, Virmani R. Anomalous right or left coronary artery from the contralateral coronary sinus: "high-risk" abnormalities in the initial coronary artery course and heterogeneous clinical outcomes. Am Heart J. 1997;133:428-435.
32. Estes M III, Link MS, Cannon D, et al. Report of the NASPE policy conference arrhythmias and the athlete. J Cardiac Electrophysiol. 2001;12:1208-1219.
33. Zipes DP, Garson A Jr. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities: Task Force 6: arrhythmias. J Am Coll Cardiol. 1994;24:892-899.
34. Maron BJ. Sudden death in young athletes: lessons from the Hank Gathers affair. N Engl J Med. 1993;329:55-57.
35. Kramer MR, Drori Y, Lev B. Sudden death in young soldiers: high Incidence of syncope prior to death. Chest. 1988;93:345-347.
36. Basilico FC. Cardiovascular disease in athletes. Am J Sports Med. 1999;27:108-121.
37. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-369.
38. Calkins H, Seifert M, Morady F. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syndrome. Am Heart J. 1995;129:1159-1164.
39. Hackel D, Reimer K. Sudden death: cardiac and other causes: role of recreational and therapeutic drugs in occurrence of sudden death. Cardiovasc Rev Rep. 1994;15:16-32.